The IP advice provided by the attorney working for Priority IP Ltd is based on a huge amount of direct scientific, commercial and private practice experience.
At Priority IP, we fully appreciates the broader commercial implications of IP rights having carried out a large number of IP DD assessments for example within the context of fund raising and investment planning such as stock market listing/IPO, and other transactional work, for example M&A, licensing and different research and development collaboration opportunities.
We are scientifically and technically highly experienced to act in all areas of life sciences and biotechnology. We were involved at an early stage in pioneering developments in the life sciences field, such as dsRNA mediated repression of gene expression. From viral oncology to vaccines, from Abs to bio-similars, from lentiviruses as vectors for gene therapy to state of the art gene editing techniques such as CRISPR/CAS-9, we have the capability to intimately acquaint ourselves with your research, appreciate its potential and effectively protect your inventions, while providing commercially relevant IP advice and direction.
We draw on our intimate knowledge and experience of microbiological and biochemical fields acquired from many years of research experience in academia and bio-pharmaceutical industries.